Furthermore, we have shown that OC-46F2, in combination with the L19-IL-2 resulted in complete inhibition of melanoma growth until day 90 from tumor implantation in 71% of treated mice with a significant increase of their tumor free survival (29). Here, IL2 is linked to melanoma.